The read at a glance
Computed from the FY2026 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score 1.35 — grey zone — between safe and distressedWatch
- Earnings-manipulation signal · Beneish M -3.32 — no flag raisedOK
- Earnings quality 86/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2026, as STAAR SURGICAL CO reports it. History and quarterly detail are in the app.
- Geographic Distribution Foreign$216.9M
- Non Consignment Sales$179.0M
- Consignment Sales$60.5M
- Geographic Distribution Domestic$22.6M
Leadership changes
From STAAR SURGICAL CO's own filings, the day they're filed.
- Warren Foust · Co-Chief Executive Officers · appointmenteff. 2026-02-01
- Stephen C. Farrell · Chief Executive Officer · departureeff. 2026-01-31
- Neal C. Bradsher · Board Chair · appointmenteff. 2026-01-15
Latest filings
- 8-K · Company announcement2026-06-09
- 10-Q · Quarterly report2026-05-13
- 8-K · Company announcement2026-05-13
- DEF 14A · Annual proxy (pay & governance)2026-05-04
- 8-K · Company announcement2026-04-08
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, every figure source-linked🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask anything about STAAR SURGICAL CO, every answer cited🔒
- The Intelligence Brief — added when STAAR SURGICAL CO's brief passes our SEC-figure check🔒
Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.